Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments

Bibliography

• Zaman MM, Rouf MA, Haque S, Does rheumatic fever occur usually between the ages of 5 and 15 years? Int J Cardiol 1998;66(1):17-21
   PubMed Web of Science ®Google Scholar
• Commerford PJ, Mayosi BM. Acute rheumatic fever. Medicine 2006;34(6):239-43
   Google Scholar
• Carapetis JR, Brown A, Wilson NJ, An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Australia 2007;186(11):581-6
   PubMed Web of Science ®Google Scholar
• Brousse V, Bahi-Buisson N, Lucet V, Acute poststreptoccocal chorea: an atypical postoperative reaction following cardiac surgery for mitral valvulopathy. Arch Pediatrie 2009;16(8):1124-8
   PubMed Web of Science ®Google Scholar
• Haffejee IE. Rheumatic fever. Clin Rheum 1995;9(1):111-20
   Web of Science ®Google Scholar
• Manyemba J, Mayosi BM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever - a systematic review. SAMJ-S Afr Med J 2003;93(3):212-18
   PubMed Web of Science ®Google Scholar
• Guilherme L, Alba MP, Ferreira FM, Anti-Group A streptococcal vaccine epitope structure, stability, and its ability to interact with HLA Class II molecules. J Biol Chem 2011;286(9):6989-98
   PubMed Web of Science ®Google Scholar
• Johri AK, Paoletti LC, Glaser P, Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006;4(12):932-42
   PubMed Web of Science ®Google Scholar
• Zaman M, Skwarczynski M, Malcolm JM, Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine. Nanomed Nanotechnol 2011;7(2):168-73
   PubMed Web of Science ®Google Scholar
• Brice E, Commerford PJ. Epidemiology and prevention of rheumatic fever and current issues in the prevention of rheumatic heart disease. Evid Based Cardiovasc Med 1998;2(4):92-3
   PubMedGoogle Scholar
• Disciascio G, Taranta A. Rheumatic-fever in children. Am Heart J 1980;99(5):635-58
   PubMed Web of Science ®Google Scholar
• Wallace MR, Garst PD, Papadimos TJ, The return of acute rheumatic fever in young-adults. JAMA 1989;262(18):2557-61
   PubMed Web of Science ®Google Scholar
• Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev 2004;17(3):571
   PubMed Web of Science ®Google Scholar
• Jarvis NT. Rheumatic fever. Prim Care 2003;10(1):9-13
   Google Scholar
• Patel NN, Patel DN. Acute Exudative Tonsillitis. Am J Med 2009;122(1):18-20
   PubMed Web of Science ®Google Scholar
• Markowitz M, Lue HC. Allergic reactions in rheumatic fever patients on long-term benzathine penicillin G: the role of skin testing for penicillin allergy. Pediatrics 1996;97(6):981-3
   PubMed Web of Science ®Google Scholar
• Singh S, Dolan JG, Centor RM. Optimal management of adults with pharyngitis – a multi-criteria decision analysis. BMC Med Inform Decis Mak 2006;6:14
   PubMedGoogle Scholar
• Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003;3(4):191-200
   PubMed Web of Science ®Google Scholar
• Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. 1. Factors related to attack rate of rheumatic fever. New Engl J Med 1961;265(12):559-66
   Web of Science ®Google Scholar
• Ehrlich JE, Demopoulos BP, Daniel KR, Cost-effectiveness of treatment options for prevention of rheumatic heart disease from group A streptococcal pharyngitis in a pediatric population. Prev Med 2002;35(3):250-7
   PubMed Web of Science ®Google Scholar
• Jacobson DL, Gange SJ, Rose NR, Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunop 1997;84(3):223-43
   PubMedGoogle Scholar
• Martin JM, Green M. Group A streptococcus. Semin Pediatr Infect Dis 2006;17(3):140-8
   PubMedGoogle Scholar
• Tart AH, Walker MJ, Musser JM. New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol 2007;15(7):318-25
   PubMed Web of Science ®Google Scholar
• Carapetis JR. Rheumatic heart disease in developing countries. New Engl J Med 2007;357(5):439-41
   PubMed Web of Science ®Google Scholar
• Kadir IS, Barker TA, Clarke B, Recurrent acute rheumatic fever: a forgotten diagnosis? Ann Thorac Surg 2004;78(2):699-701
   PubMed Web of Science ®Google Scholar
• Alehan D, Ayabakan C, Hallioglu O. Role of serum cardiac troponin T in the diagnosis of acute rheumatic fever and rheumatic carditis. Heart 2004;90(6):689-90
   PubMed Web of Science ®Google Scholar
• Barsaoui S. Rhumatisme articulaire aigu chez l'enfant. EMC-Pediatrie 2005;2(3):243-55
   Google Scholar
• Olivier C. Rheumatic fever: is it still a problem? J Antimicrob Chemoth 2000;45(Suppl):13-21
   PubMed Web of Science ®Google Scholar
• WHO. The WHO global programme for the prevention of rheumatic fever and rheumatic heart disease. Geneva: World Health Organization; 1999
   Google Scholar
• Carapetis JR, Steer AC, Mulholland EK, The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5(11):685-94
   PubMed Web of Science ®Google Scholar
• Hillman ND, Tani LY, Veasy LG, Current status of surgery for rheumatic carditis in children. Ann Thorac Surg 2004;78(4):1403-8
   PubMed Web of Science ®Google Scholar
• Lee JL, Naguwa SM, Cheema GS, Acute rheumatic fever and its consequences: a persistent threat to developing nations in the 21st century. Autoimmun Rev 2009;9(2):117-23
   PubMed Web of Science ®Google Scholar
• Seckeler MD, Hoke TR, Gurka MJ, No demonstrable effect of benzathine penicillin on recurrence of rheumatic fever in Pacific Island population. Pediatr Cardiol 2010;31(6):849-52
   PubMed Web of Science ®Google Scholar
• Watkins DA, Mayosil BM. Benzathine penicillin for recurrence of rheumatic fever: the jury is still out. Pediatr Cardiol 2011;32(2):247-7
   PubMed Web of Science ®Google Scholar
• Dajani AS, Ayoub E, Bierman FZ, Guidelines for the diagnosis of rheumatic fever - Jones criteria, 1992 update. JAMA 1992;268(15):2069-73
   PubMed Web of Science ®Google Scholar
• Roodpeyma S, Kamali Z, Zare R. Rheumatic fever: the relationship between clinical manifestations and laboratory tests. J Paediatr Child Health 2005;41(3):97-100
   PubMed Web of Science ®Google Scholar
• Kaplan EL. Rheumatic fever: 6 decades after Jones criteria. Int J Cardiol 2007;122:13
   Web of Science ®Google Scholar
• Ralph A, Jacups S, McGough K, The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed. Heart Lung Circ 2006;15(2):113-18
   PubMedGoogle Scholar
• Stollerman GH. Rheumatic fever. Lancet 1997;349(9056):935-42
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Molecular mimicry, autoimmunity and infection in the pathogenesis of rheumatic fever. Int Congr Ser 2006;1289:14-19
   Google Scholar
• Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011;8(3):162-72
   PubMed Web of Science ®Google Scholar
• Zakkar M, Amirak E, Chan KMJ, Rheumatic mitral valve disease: current surgical status. Prog Cardiovasc Dis 2009;51(6):478-81
   PubMed Web of Science ®Google Scholar
• Bisno AL, Stevens DL. Current concepts –. Streptococcal infections of skin and soft tissues. New Engl J Med 1996;334(4):240-5
   PubMed Web of Science ®Google Scholar
• Kivity S, Agmon-Levin N, Blank M, Infections and autoimmunity – friends or foes? Trends Immunol 2009;30(8):409-14
   PubMed Web of Science ®Google Scholar
• Rose NR. The role of infection in the pathogenesis of autoimmune disease. Semin Immuno 1998;10(1):5-13
   Web of Science ®Google Scholar
• Ben-Yehuda O, DeMaria AN. Statins in rheumatic heart disease taking the bite out? J Am Coll Cardiol 2009;53(20):1880-2
   PubMed Web of Science ®Google Scholar
• Catanzaro FJ, Stetson CA, Morris AJ, The role of the streptococcus in the pathogenesis of rheumatic fever. Am J Med 1954;17(6):749-56
   PubMed Web of Science ®Google Scholar
• Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol 2007;66(2-3):199-207
   PubMed Web of Science ®Google Scholar
• Guilherme L, Kalil J. Rheumatic fever: the T cell response leading to autoimmune aggression in the heart. Autoimmun Rev 2002;1(5):261-6
   PubMedGoogle Scholar
• Kafetzis DA, Liapi G, Tsolia M, Failure to eradicate Group A beta-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment. Int J Antimicrob Ag 2004;23(1):67-71
   PubMed Web of Science ®Google Scholar
• Musser JM, Shelburne SA. A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest 2009;119(9):2455-63
   PubMed Web of Science ®Google Scholar
• Chiappini E, Regoli M, Bonsignori F, Analysis of different recommendations from international Guidelines for the Management of Acute Pharyngitis in Adults and Children. Clin Ther 2011;33(1):48-58
   PubMed Web of Science ®Google Scholar
• Furst DE, Keystone EC, Braun J, Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010. Ann Rheum Dis 2011;70:I2-I36
   PubMed Web of Science ®Google Scholar
• Chamovitz R, Catanzaro FJ, Stetson CA, Prevention of rheumatic fever by treatment of previous streptococcal infection. 1. Evaluation of benzathine penicillin-G. New Engl J Med 1954;251(12):466-71
   PubMed Web of Science ®Google Scholar
• Stollerman GH. The use of antibiotics for the prevention of rheumatic fever. Am J Med 1954;17(6):757-67
   PubMed Web of Science ®Google Scholar
• Stollerman GH, Rusoff JH. Prophylaxis against Group A streptococcal infections in rheumatic fever patients – Use of new repository penicillin preparation. JAMA 1952;150(16):1571-5
   PubMed Web of Science ®Google Scholar
• Khan IA, Ijaz N. Prophylaxis of infective endocarditis: current perspectives. Int J Cardiol 2009;134(3):E105-E06
   PubMed Web of Science ®Google Scholar
• Massell BF, Dow JW, Jones TD. Orally administered penicillin in patients with rheumatic fever. JAMA 1948;138(14):1030-6
   PubMed Web of Science ®Google Scholar
• Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005;5(1):11
   PubMedGoogle Scholar
• Lennon D. Acute rheumatic fever in children: recognition and treatment. Paediatrics Drugs 2004;6(6):363-73
   PubMedGoogle Scholar
• Cooper RJ, Hoffman JR, Bartlett JC, Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001;134(6):509-17
   PubMed Web of Science ®Google Scholar
• Bach DS. Perspectives on the American College of Cardiology/American Heart Association Guidelines for the prevention of infective endocarditis. J Am Coll Cardiol 2009;53(20):1852-4
   PubMed Web of Science ®Google Scholar
• Cohen R.. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Pediatr Infect Dis J 2004;23(2 Suppl):129-34
   Web of Science ®Google Scholar
• Denny FW, Wannamaker LW, Brink WR, Prevention of rheumatic fever - treatment of the preceding streptococci infection. JAMA 1950;143(2):151-3
   PubMed Web of Science ®Google Scholar
• Currie BJ.. Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever? Pediatrics 1996;97(6):989-91
   PubMed Web of Science ®Google Scholar
• Wannamaker LW, Rammelkamp CH, Denny FW, Prophylaxis of acute rheumatic fever - by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med 1951;10(6):673-95
   PubMed Web of Science ®Google Scholar
• Schwartz B, Marcy SM, Phillips WR, Pharyngitis - Principles of judicious use of antimicrobial agents. Pediatrics 1998;101(1):171-4
   Web of Science ®Google Scholar
• Shulman ST, Gerber MA. So what's wrong with penicillin for strep throat? Pediatrics 2004;113(6):1816-19
   PubMed Web of Science ®Google Scholar
• Kassem AS, Zaher SR, AbouShleib H, Rheumatic fever prophylaxis using benzathine penicillin G (BPG): two-week versus four-week regimens: Comparison of two brands of BPG. Pediatrics 1996;97(6):992-5
   PubMed Web of Science ®Google Scholar
• Jerath N, Shetty G. Redefining the management of pediatric tonsillopharyngitis with cefprozil. Indian J Pediatr 2007;74(12):1105-8
   PubMed Web of Science ®Google Scholar
• Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 2004;113(4):866-82
   PubMed Web of Science ®Google Scholar
• Nemeth MA, McCarty J, Gooch WM, Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Clin Ther 1999;21(11):1873-81
   PubMed Web of Science ®Google Scholar
• Martin JM, Green M, Barbadora KA, Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. New Engl J Med 2002;346(16):1200-6
   PubMed Web of Science ®Google Scholar
• Nemeth MA, Gooch WM, Hedrick J, Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis. Clin Ther 1999;21(9):1525-32
   PubMed Web of Science ®Google Scholar
• Peloso UC, De Souza JCR, Botino MA, Penicillin concentrations in sera and tonsils after intramuscular administration of benzathine penicillin G to children. Pediatr Infect Dis J 2003;22(12):1075-8
   PubMed Web of Science ®Google Scholar
• Ono M, Aoki Y, Masumoto M, High-dose penicillin G-treatment causes underestimation of serum albumin measured by a modified BCP method. Clin Chim Acta 2009;407(1-2):75-6
   PubMed Web of Science ®Google Scholar
• Alvarez J, Padilla J, Williams S, Duration of antimicrobial prophylaxis for group B streptococcus in patients with preterm premature rupture of membranes who are not in labor. Am J Obstet Gynecol 2007;197(4):390.e1-4
   PubMed Web of Science ®Google Scholar
• Bass JW. A review of the rationale and advantages of various mixtures of benzathine penicillin G. Pediatrics 1996;97(6):960-3
   PubMed Web of Science ®Google Scholar
• Martinez-Landeira P, Gonzalez-Perez A, Ruso JM, Colloidal properties of benzylpenicillin - Comparison with structurally related penicillins. Colloid Surf A-Physicochem Eng Asp 2004;236(1-3):121-31
   Web of Science ®Google Scholar
• Bilavsky E, Eliahou R, Keller N, Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever. J Infection 2008;56(4):244-8
   PubMed Web of Science ®Google Scholar
• Brook I. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis. Int J Pediatr Otorhi 2007;71(10):1501-8
   PubMed Web of Science ®Google Scholar
• Bonacucina G, Cespi M, Misici-Falzi M, Colloidal soft matter as drug delivery system. J Pharm Sci 2009;98(1):1-42
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Chaubal MV, Shorr R. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliver Rev 2008;60(6):757-67
   PubMed Web of Science ®Google Scholar
• Kapitza SB, Michel BR, van Hoogevest P, Absorption of poorly water-soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model. Eur J Pharm Biopharm 2007;66(1):146-58
   PubMed Web of Science ®Google Scholar
• Sezgin Z, Yuksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs (vol 64, pg 261, 2006). Eur J Pharm Biopharm 2007;67(1):300
   Web of Science ®Google Scholar
• Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007;24(1):1-16
   PubMed Web of Science ®Google Scholar
• Barratt G. Therapeutic applications of colloidal drug carriers. Pharm Sci Technol Toxicol 2000;3(5):163-71
   PubMedGoogle Scholar
• Lira MCB, Siqueira-Moura MP, Rolim-Santos HML, In vitro uptake and antimycobacterial activity of liposomal usnic acid formulation. J Lipos Res 2009;19(1):49-58
   PubMed Web of Science ®Google Scholar
• Li P, Hynes SR, Haefele TF, Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. J Pharm Sci 2009;98(5):1750-64
   PubMed Web of Science ®Google Scholar
• Pestana KC, Formariz TP, Franzini CM, Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B. Colloid Surface B 2008;66(2):253-9
   PubMed Web of Science ®Google Scholar
• Formariz TP, Chiavacci LA, Scarpa MV, Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin. Colloid Surface B 2010;77(1):47-53
   PubMed Web of Science ®Google Scholar
• Heuschkel S, Goebel A, Neubert RHH. Microemulsions – Modern colloidal carrier for dermal and transdermal drug delivery. J Pharm Sci 2008;97(2):603-31
   PubMed Web of Science ®Google Scholar
• Homar M, Dreu R, Kerc J, Preparation and evaluation of celecoxib-loaded microcapsules with self-microemulsifying core. J Microencapsul 2009;26(6):479-84
   PubMed Web of Science ®Google Scholar
• Paul BK, Moulik SP. Uses and applications of microemulsions. Curr Sci India 2001;80(8):990-1001
   Web of Science ®Google Scholar
• Spernath A, Aserin A. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interfac 2006;128:47-64
   PubMed Web of Science ®Google Scholar
• Tomsic M, Podlogar F, Gasperlin M, Water-Tween 40 (R)/Imwitor 308 (R)-isopropyl myristate microemulsions as delivery systems for ketoprofen: small-angle X-ray scattering study. Int J Pharm 2006;327(1-2):170-7
   PubMed Web of Science ®Google Scholar
• Gupta S, Moulik SP. Biocompatible microemulsions and their prospective uses in drug delivery. J Pharm Sci 2008;97(1):22-45
   PubMed Web of Science ®Google Scholar
• Silva JA, Bedor DCG, Damasceno B, Physicochemical characterization and development of a microemulsion system for transdermal use. J Disper Sci Technol 2010;31(1):1-8
   Web of Science ®Google Scholar
• Zvonar A, Rozman B, Rogac MB, The influence of microstructure on Celecoxib release from a pharmaceutically applicable system: mygliol 812 (R)/Labrasol (R)/Plurol Oleique (R)/Water mixtures. Acta Chim Slov 2009;56(1):131-8
   Web of Science ®Google Scholar
• Pontes ACO, Caetano MNP, Santos-Magalhaes NS. Physicochemical characterization and antimicrobial activity of benzathine penicillin G liposomes. STP Pharma 1999;9(5):419-28
   Web of Science ®Google Scholar
• Santos-Magalhaes NS, Pontes A, Pereira VMW, Colloidal carriers for benzathine penicillin G. Nanoemulsions and nanocapsules. Int J Pharm 2000;208(1-2):71-80
   PubMed Web of Science ®Google Scholar
• Khoee S, Yaghoobian M. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur J Med Chem 2009;44(6):2392-9
   PubMed Web of Science ®Google Scholar
• Silva KGH, Xavier Junior FH, Farias IEG, A new insight about pharmaceutical dosage forms for benzathine penicillin G. Rev Cienc Farm 2006;27:21-6
   Google Scholar